2016
MiR-338-5p sensitizes glioblastoma cells to radiation through regulation of genes involved in DNA damage response
BEŠŠE, Andrej, Jiří ŠÁNA, Radek LAKOMÝ, Leoš KŘEN, Pavel FADRUS et. al.Základní údaje
Originální název
MiR-338-5p sensitizes glioblastoma cells to radiation through regulation of genes involved in DNA damage response
Autoři
BEŠŠE, Andrej (703 Slovensko, domácí), Jiří ŠÁNA (203 Česká republika, domácí), Radek LAKOMÝ (203 Česká republika, domácí), Leoš KŘEN (203 Česká republika, domácí), Pavel FADRUS (203 Česká republika, domácí), Martin SMRČKA (203 Česká republika, domácí), Markéta HERMANOVÁ (203 Česká republika, domácí), Radim JANČÁLEK (203 Česká republika, domácí), Stefan REGULI (203 Česká republika), Radim LIPINA (203 Česká republika), Marek SVOBODA (203 Česká republika, domácí), Pavel ŠLAMPA (203 Česká republika) a Ondřej SLABÝ (203 Česká republika, garant, domácí)
Vydání
Tumor Biology, Dordrecht, Springer, 2016, 1010-4283
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30200 3.2 Clinical medicine
Stát vydavatele
Nizozemské království
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 3.650
Kód RIV
RIV/00216224:14740/16:00088839
Organizační jednotka
Středoevropský technologický institut
UT WoS
000376464700071
Klíčová slova česky
Multiformní glioblastom; radiace; resistence; miRNA; miR-338-5p
Klíčová slova anglicky
Glioblastoma multiforme; GBM; Radiation resistance; miRNA; miRNA338-5p
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 25. 1. 2017 16:33, Mgr. Eva Špillingová
Anotace
V originále
Glioblastoma multiforme (GBM) is the most aggressive form of brain tumor. Despite radical surgery and radiotherapy supported by chemotherapy, the disease still remains incurable with an extremely low median survival rate of 12-15 months from the time of initial diagnosis. The main cause of treatment failure is considered to be the presence of cells that are resistant to the treatment. MicroRNAs (miRNAs) as regulators of gene expression are involved in the tumor pathogenesis, including GBM. MiR-338 is a brain-specific miRNA which has been described to target pathways involved in proliferation and differentiation. In our study, miR-338-3p and miR-338-5p were differentially expressed in GBM tissue in comparison to non-tumor brain tissue. Overexpression of miR-338-3p with miRNA mimic did not show any changes in proliferation rates in GBM cell lines (A172, T98G, U87MG). On the other hand, pre-miR-338-5p notably decreased proliferation and caused cell cycle arrest. Since radiation is currently the main treatment modality in GBM, we combined overexpression of pre-miR-338-5p with radiation, which led to significantly decreased cell proliferation, increased cell cycle arrest, and apoptosis in comparison to irradiation-only cells. To better elucidate the mechanism of action, we performed gene expression profiling analysis that revealed targets of miR-338-5p being Ndfip1, Rheb, and ppp2R5a. These genes have been described to be involved in DNA damage response, proliferation, and cell cycle regulation. To our knowledge, this is the first study to describe the role of miR-338-5p in GBM and its potential to improve the sensitivity of GBM to radiation.
Návaznosti
ED1.1.00/02.0068, projekt VaV |
| |
NT13514, projekt VaV |
|